Postmenopausal estrogen therapy and serum estradiol fatty acid esters in women with and without previous intrahepatic cholestasis of pregnancy

References

• de Ziegler D. Is the liver a target organ for estrogen? In: Sitruk-Ware R, Utian WH, editors. The menopause and hormonal replacement therapy: facts and controversies. New York: Marcel Dekker Inc; 1991:201–26.
   Google Scholar
• Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause 2001; 8: 200–3.
   PubMed Web of Science ®Google Scholar
• Crook D. The metabolic consequences of treating postmeno-pausal women with non-oral hormone replacement therapy. Br J Obstet Gynaecol 1997;104:4–13.
   Google Scholar
• Vihma V, Vehkavaara S, Yki-Järvinen H, Hohtari H, Tikkanen MJ. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women. J Clin Endocrinol Metab 2003;88:588–93.
   Google Scholar
• Hochberg RB. Biological esterification of steroids. Endocr Rev 1998;19:331–48.
   Google Scholar
• Vihma V, Tiitinen A, Ylikorkala 0, Tikkanen MJ. Quanti-tative determination of estradiol fatty acid esters in lipopro-tein fractions in human blood. J Clin Endocrinol Metab 2003; 88:2552–5.
   Google Scholar
• Tikkanen MJ, Vihma V, Jauhiainen M, Höckerstedt A, Helisten H, Kaamanen M. Lipoprotein-associated estrogens. Cardiovasc Res 2002;56:184–8.
   PubMedGoogle Scholar
• Germain AM, Carvajal JA, Glasinovic JC, Kato CS, William-son C. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. J Soc Gynecol Investig 2002; 9: 10–4.
   Google Scholar
• Tikkanen MJ, Adlercreutz H. Recurrent jaundice in preg-nancy. III. Quantitative determination of urinary estriol conjugates, including studies in pruritus gravidarum. Am J Med 1973;54:600–4.
   Google Scholar
• Adlercreutz H, Tikkanen MJ, Wichmann K, Svanborg A, Anberg A. Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum. J Clin Endocrinol Metab 1974; 38:51–7.
   Google Scholar
• Kreek MJ, Weser E, Sleisenger MH, Jeffries GH. Idiopathic cholestasis of pregnancy. The response to challenge with the synthetic estrogen, ethinyl estradiol. N Engl J Med 1967;277: 1391–5.
   Google Scholar
• Drill VA. Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives. Am J Obstet Gynecol 1974;119:165–74.
   Google Scholar
• Reyes H, Ribalta J, Gonzalez MC, Segovia N, Oberhauser E. Sulfobromophthalein clearance tests before and after ethinyl estradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenter-ology 1981;81:226–31.
   Google Scholar
• Vihma V, Adlercreutz H, Tiitinen A, Kiuru P, Wähälä K, Tikkanen MJ. Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid. Clin Chem 2001;47:1256–62.
   Google Scholar
• Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206–23.
   Google Scholar
• De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, et al. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986; 62:536–41.
   Google Scholar
• Scott RT, Jr, Ross B, Anderson C, Archer DF. Pharmacoki-netics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991;77:758–64.
   Google Scholar
• Steingold KA, Matt DW, De Ziegler D, Sealey JE, Fratkin M, Reznikov S. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab 1991;73:275–80.
   PubMed Web of Science ®Google Scholar
• Germain AM, Kato S, Carvajal J, Fredes A, Nien JK, Valenzuela GJ, et al. Intrahepatic cholestasis of pregnancy. A model of premature initiation of parturition. J Soc Gynecol Invest 1999;6:204A–5A.
   Google Scholar
• Sjövall K, Sjövall J. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann Clin Res 1970;2:321–37.
   PubMedGoogle Scholar
• Vihma V. 173-Estradiol fatty acid esters in pregnancy serum and lipoproteins. In: Lipoprotein-associated 1713-estradiol fatty acid esters in pregnancy and during postmenopausal estrogen therapy. Helsinki: Helsinki University Press; 2003: 35–8.
   Google Scholar
• Ory SJ, Field CS, Herrmann RR, Zinsmeister AR, Riggs BL. Effects of long-term transdermal administration of estradiol on serum lipids. Mayo Clin Proc 1998;73:735–8.
   Google Scholar
• Höckerstedt A, Tikkanen MJ, Jauhiainen M. LCAT facili-tates transacylation of 17beta-estradiol in the presence of HDL3 subfraction. J Lipid Res 2002;43: 392–7.
   Google Scholar
• Leszczynski DE, Schafer RM. Metabolic conversion of six steroid hormones by human plasma high-density lipoprotein. Biochim Biophys Acta 1991;1083:18–28.
   Google Scholar
• Pahuj a SL, Hochberg RB. A comparison of the esterification of steroids by rat lecithin:cholesterol acyltransferase and acyl coenzyme A:cholesterol acyltransferase. Endocrinology 1995; 136:180–6.
   Google Scholar
• Kanji SS, Kuohung W, Labaree DC, Hochberg RB. Regio-specific esterification of estrogens by lecithin:cholesterol acyltransferase. J Clin Endocrinol Metab 1999;84:2481–8.
   Google Scholar
• Helisten H, Höckerstedt A, Wähälä K, Tiitinen A, Adler-creutz H, Jauhiainen M, et al. Accumulation of high-density lipoprotein-derived estradiol-17beta fatty acid esters in low-density lipoprotein particles. J Clin Endocrinol Metab 2001; 86:1294–300.
   PubMed Web of Science ®Google Scholar
• Abplanalp W, Scheiber MD, Moon K, Kessel B, Liu JH, Subbiah MT. Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens. Eur J Endocrinol 2000;142:79–83.
   PubMed Web of Science ®Google Scholar
• Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003;111:1579–87.
   PubMed Web of Science ®Google Scholar
• Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000;190:244–54.
   PubMed Web of Science ®Google Scholar